RA
GSK icon

RFG Advisory’s GSK GSK Stock Holding History

RFG Advisory’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$964K Buy
18,391
+1,768
+11% +$93.5K 0.02% 586
2026
Q1 		$917K Sell
16,623
-10,663
-39% -$578K 0.02% 563
2025
Q4 		$1.34M Buy
+27,286
New +$1.27M 0.03% 446
2024
Q2 		– Sell
-5,576
Closed -$239K – 722
2024
Q1 		$239K Sell
5,576
-96
-2% -$3.96K 0.01% 653
2023
Q4 		$210K Sell
5,672
-401
-7% -$14.4K 0.01% 627
2023
Q3 		$220K Sell
6,073
-18
-0.3% -$639 0.01% 579
2023
Q2 		$217K Buy
6,091
+32
+0.5% +$1.15K 0.01% 591
2023
Q1 		$216K Sell
6,059
-506
-8% -$17.7K 0.01% 584
2022
Q4 		$229K Sell
6,565
-5,461
-45% -$182K 0.01% 566
2022
Q3 		$387K Buy
12,026
+1,766
+17% +$66.9K 0.02% 430
2022
Q2 		$520K Buy
10,260
+6,066
+145% +$335K 0.03% 348
2022
Q1 		$228K Sell
4,194
-270
-6% -$14.7K 0.01% 465
2021
Q4 		$246K Buy
+4,464
New +$232K 0.02% 429
2017
Q2 		– Sell
-11,943
Closed -$626K – 136
2017
Q1 		$626K Buy
11,943
+5,773
+94% +$293K 0.47% 49
2016
Q4 		$335K Hold
6,170
– – 0.32% 64
2016
Q3 		$334K Buy
6,170
+14
+0.2% +$768 0.31% 65
2016
Q2 		$334K Buy
6,156
+239
+4% +$12.6K 0.29% 66
2016
Q1 		$300K Buy
5,917
+955
+19% +$47.6K 0.23% 72
2015
Q4 		$250K Buy
4,962
+648
+15% +$33K 0.18% 45
2015
Q3 		$207K Sell
4,314
-88
-2% -$4.58K 0.67% 50
2015
Q2 		$229K Buy
+4,402
New +$248K 0.1% 140

Other funds holding GSK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
TH
Transmarket Holdings Chicago, Illinois $136M AUM

RFG Advisory's GSK Position: Q2 2026 in Review

RFG Advisory increased its GSK (GSK) stake by 11% in Q2 2026, buying an estimated $93.5K and bringing the position to 18,391 shares worth $964K. The position accounts for 0.02% of the portfolio, ranked #586.

RFG Advisory first reported a position in GSK in Q2 2015 and has held it in 21 quarters since. The position peaked at $1.34M in Q4 2025. 296 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • RFG Advisory held 18,391 shares of GSK worth $964K as of Q2 2026.
  • RFG Advisory bought 1,768 GSK shares in Q2 2026, an estimated $93.5K.
  • GSK made up 0.02% of RFG Advisory's portfolio in Q2 2026, its #586 holding.
  • RFG Advisory first reported a position in GSK in Q2 2015 and has held it in 21 quarters since.
  • RFG Advisory's GSK position peaked at $1.34M in Q4 2025.
  • 296 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on RFG Advisory's 13F filing for Q2 2026, filed 15 Jul 2026.